Clindamycin "Hameln" 150 mg/ml injektions-/infusionsvæske, opløsning Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

clindamycin "hameln" 150 mg/ml injektions-/infusionsvæske, opløsning

hameln pharma gmbh - clindamycinphosphat - injektions-/infusionsvæske, opløsning - 150 mg/ml

Ozawade Euroopa Liit - taani - EMA (European Medicines Agency)

ozawade

bioprojet pharma - pitolisant - sleep apnea, obstructive - andre narkotika stoffer - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).